Csenge Advisory Group Meridian Bioscience Inc Transaction History

Csenge Advisory Group

  • $1.97 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 21, 2021
SELL
$18.01 - $28.32 $204,143 - $321,007
-11,335 Closed
0 $0
Q1 2021

Apr 28, 2021
BUY
$19.76 - $29.89 $223,979 - $338,803
11,335 New
11,335 $284,000
Q4 2018

Feb 07, 2019
SELL
$14.52 - $19.72 $159 - $216
-11 Closed
0 $0
Q3 2018

Nov 19, 2018
BUY
$14.85 - $16.35 $163 - $179
11 New
11 $0

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email